MGH opens first-of-its-kind center to eliminate lifelong immunosuppression after organ transplant

Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, officially opened the Legorreta Center for Clinical Transplant Tolerance, the first-of-its kind center in the world dedicated to preventing organ rejection after transplant surgery without the use of lifelong immunosuppressive medications.

Related Keywords

United States ,Massachusetts ,Pablo Legorreta ,David Sachs ,A Benedict Cosimi ,Megan Sykes ,Jorenc Madsen ,Thomas Spitzer ,Tatsuo Kawai ,Almudena Legorreta ,Janet Mccourt ,Lily Ramsey ,Legorreta Center ,Legorreta Endowed Fund For The Center ,Kawai ,General Hospital ,Mass General Brigham ,Clinical Transplant Tolerance ,Chief Executive Officer ,Royalty Pharma ,Legorreta Endowed Fund ,Hospital ,Transplant ,Flood ,One ,Bone Marrow ,Dancer ,Diabetes ,Heart ,Heart Disease ,Immune System ,Immunosuppression ,Kidney ,Kidney Transplant ,Myeloma ,Research ,Stem Cells ,Surgery ,